NASDAQ:ADMA - ADMA Biologics, Inc.
$3.73
 $-0.16
-4.11%
4:00PM EDT
2019-07-22
ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments include Plasma Collection Centers, which includes its operations in Georgia; Research and Development, which includes its plasma development operations in New Jersey, and Corporate. Its targeted patient populations are immune-compromised individuals suffering from an underlying immune deficiency disorder or may be immune-suppressed for medical reasons. Its product candidates are intended to be used by physician specialists focused on caring for immune-compromised patients at risk of contracting infectious diseases. Its intravenous immunoglobulin product candidate, RI-002, is intended for the treatment of primary immune deficiency disease. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ADMA     avg for
industry  
  avg for
sector  
42 stocks weight:  18. 55   0. 00   0. 00  
42 stocks rank:  3. 41 K 1. 35 K 799. 74  
# analyst opinions:  8. 00   12. 76   13. 14  
mean recommendation:  1. 70   2. 11   2. 07  

quick ratio:  2. 14   5. 61   1. 85  
current ratio:  4. 60   6. 00   2. 31  

target price low:  3. 80   75. 88   108. 31  
target price avg:  4. 77   97. 27   130. 10  
target price high:  8. 00   124. 58   149. 02  
1-yr high:  6. 85   104. 89   135. 09  
last close:  3. 73   79. 79   118. 76  
50-day avg:  4. 02   79. 39   116. 18  
200-day avg:  4. 26   81. 61   114. 52  
1-yr low:  2. 17   62. 76   94. 70  
volume:  553. 07 K 2. 99 M 4. 43 M
50-day avg volume:  1. 05 M 3. 39 M 4. 22 M
200-day avg volume:  742. 19 K 3. 13 M 4. 83 M

1-day return:  -4. 11 % 0. 33 % 0. 14 %
this week return:  -4. 11 % 0. 33 % 0. 14 %
12-wk return:  -23. 41 % 1. 00 % 3. 51 %
52-wk return:  -21. 26 % 0. 58 % 10. 25 %

enterprise value (EV):  221. 32 M 44. 78 B 115. 63 B
market cap:  203. 45 M 38. 01 B 103. 29 B
EBITDA:  -54. 14 M 4. 47 B 7. 73 B
enterprise multiple (EV/EBITDA):  -4. 09   2. 11   11. 26  
enterprise/revenue (EV/R):  13. 44   61. 53   10. 40  
total revenue:  16. 47 M 10. 43 B 31. 15 B
total debt:  57. 44 M 11. 72 B 16. 76 B
debt/equity:  572. 15   61. 22   124. 43  
net income (common):  -60. 99 M 2. 06 B 3. 79 B

shares outstanding:  46. 38 M 562. 08 M 1. 27 B
shares:  21. 27 M 573. 33 M 1. 26 B
shares short:  4. 28 M 11. 60 M 12. 29 M
shares short prior month:  3. 99 M 9. 81 M 12. 46 M
short ratio:  4. 18   5. 88   3. 41  
short % of float:  18. 62 % 6. 88 % 2. 72 %
total cash/share:  0. 36   10. 62   8. 83  
total cash:  16. 53 M 6. 17 B 5. 72 B
free cash flow:  -37. 40 M 3. 08 B 3. 10 B
operating cash flow:  -60. 53 M 3. 99 B 4. 08 B

book value:  0. 22   12. 74   26. 25  
price/book:  17. 19   4. 38   9. 01  
gross profits:  -25. 21 M 7. 93 B 35. 64 B
operating margins:  -345. 83 % -319. 65 % -29. 05 %
EBITDA margins:  0. 00 % 11. 82 % 24. 13 %
profit margins:  0. 00 % 5. 62 % 14. 29 %
gross margins:  -138. 93 % 34. 75 % 57. 07 %

1-yr max volatility:  45. 51 % --- ---
1-yr mean volatility:  3. 35 % 1. 95 % 1. 25 %

1-yr EPS:  -1. 34   1. 58   3. 82  
forward EPS:  -0. 58   3. 16   6. 65  
P/E:  -2. 78   0. 21   31. 97  
forward P/E:  -6. 71   4. 95   15. 14  
PE/G:  0. 22   0. 74   0. 13  
growth:  -12. 70 % 295. 81 % 85. 47 %
earnings high:  -0. 13   0. 84   1. 56  
earnings avg:  -0. 29   0. 65   1. 45  
earnings low:  -0. 38   0. 40   1. 35  
revenue high:  4. 03 M 2. 70 B 8. 76 B
revenue avg:  3. 34 M 2. 64 B 8. 62 B
revenue low:  2. 49 M 2. 58 B 8. 45 B
return on assets:  -42. 07 % -3. 43 % 4. 51 %
return on equity:  -368. 91 % -104. 30 % 140. 44 %
revenue growth:  -12. 70 % 295. 25 % 78. 55 %
revenue/share:  0. 36   12. 50   51. 58  

beta (1yr vs S&P500):  1. 02   1. 27   0. 91  
sharpe (1yr):  0. 17   0. 20   0. 80  

held % insiders:  25. 50 % 6. 63 % 3. 46 %
held % institutions:  57. 51 % 76. 45 % 67. 87 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-22 : ADMA
.     101.52 =        101.52 :: --> INITIAL WEIGHT <--
.    - 1.342 =       100.178 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.838 =       284.278 :: P/E factor
.    x 1.462 =       415.628 :: PE/G factor
.    x 1.685 =       700.332 :: beta factor
.      x 0.7 =       489.893 :: sharpe factor
.    x 2.766 =      1354.985 :: current ratio factor
.     x 1.37 =      1856.474 :: quick ratio factor
.    x 1.113 =      2066.644 :: short ratio factor
.    x 1.218 =      2517.915 :: EV/R factor
.    x 1.154 =       2904.47 :: price-to-book factor
.    x 0.741 =      2151.713 :: debt-to-revenue factor
.    x 2.382 =       5126.29 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.759 =     14144.638 :: sector+industry 1-year gains factor
.     x 1.01 =     14285.873 :: industry 12-weeks return factor
.    x 1.309 =     18705.443 :: industry 2-weeks return factor
.    x 0.978 =      18301.52 :: "drift" penalty 3 days ago
.    x 0.975 =     17847.844 :: "drift" penalty 5 days ago
.    / 2.068 =      8629.186 :: overall "drift" factor
.    x 0.834 =      7200.908 :: largest single-day jump factor
.    x 0.074 =       535.383 :: low price factor
.    x 1.056 =       565.273 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.336 =       190.158 :: forward EPS factor
.    x 0.759 =       144.303 :: forward P/E factor
.    x 1.184 =       170.849 :: industry recommendation factor
.    x 2.677 =       457.433 :: company recommendation factor
.    x 1.002 =       458.128 :: factor historical industry gain for week 29
.    x 1.171 =       536.339 :: target low factor
.    x 1.176 =       630.951 :: target mean factor
.    x 1.045 =       659.305 :: target high factor
.    x 5.043 =      3324.813 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         7.593 :: reduced for readability
.   + 10.952 =        18.545 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     18.545 :: FINAL WEIGHT for NASDAQ:ADMA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org